Medication-Taking Behavior in a Cohort of Patients with Inflammatory Bowel Disease
Recent studies have shown a low adherence rate to maintenance treatment in patients with inflammatory bowel disease (IBD). We sought to assess the medication-taking behavior in a cohort of patients with IBD. We prospectively included IBD patients from the outpatient clinic who agreed to answer a questionnaire about prescribed treatment and adherence. Physicians registered clinical data including prescribed medications. Two hundred fourteen patients (115 Crohn's disease/99 ulcerative colitis) were included. The most prescribed medications were oral mesalazine (56.5%) and immunomodulators (41.1%). Forty-three percent of patients admitted to occasionally forgetting to take their medication but only 7.5% of them did it voluntary. Oral mesalazine and azathioprine were the drugs with the poorest compliance, with nonadherence rates of 45% and 25% of the total prescribed doses, respectively. The only factor associated with a better adherence was a more complicated course of the disease—steroid dependency, steroid refractoriness, need for infliximab treatment, hospitalization, or surgery (P=.02). Twenty percent of patients admitted to self-medicating. An important proportion of patients with IBD admit to forget some doses of the prescribed medication in the setting of a specialized unit of a referral centre.
KeywordsInflammatory bowel disease Ulcerative colitis Crohn's disease Adherence Compliance Self-medication Mesalazine Azathioprine
- 1.Haynes RB (2001) Improving patient adherence: state of the art, with a special focus on medication taking for cardiovascular disorders. In: Compliance in Health Care and research. Burke LE, Ockene IS, eds. New York: Futura Publishing; pp 3–21Google Scholar
- 3.Kane SV, Cohen RD, Aikens JE, Hanauer SB (2001) Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis. Am J Gastroenterol 96:2933Google Scholar
- 7.DiMatteo MR (1997) Adherence to treatment. In: Feldman MD, Christensen JF, eds. Behavioral medicine. A primary care handbook. New York: Appleton & Lange; 136–140Google Scholar
- 11.Moody GA, Jayanthi V, Probert CS, Mac Kay H, Mayberry JF (1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8:1179–1183PubMedGoogle Scholar
- 20.Gasche C, Scholmerich J, Brynskov J, et al (1998) A simple classification of Crohn's disease: report of the working party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 5:8–15Google Scholar